Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A Clinician's Guide to Pemphigus VulgarisClinical Research Introduction

A Clinician's Guide to Pemphigus Vulgaris: Clinical Research Introduction [Pemphigus vulgaris is a severe autoimmune disease diagnosed by painful erosions and extensive blistering of the skin and mucous membranes. Autoantibodies against epicutaneous antigens cause the blisters and erosions in pemphigus vulgaris. Among them, antigens such as desmoglein 1 and 3 are of particular importance. The aim of the author’s study was to determine the relationship between the levels of autoantibodies against desmoglein 1 and 3, using the enzyme-linked immunosorbent assay (ELISA) method in patients newly diagnosed with pemphigus vulgaris, and timeline of the disease among the patients hospitalized in Razi Hospital, Tehran, Iran, during 2013–2014.] http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png

A Clinician's Guide to Pemphigus VulgarisClinical Research Introduction

Download PDF
5 pages

Loading next page...
 
/lp/springer-journals/a-clinician-s-guide-to-pemphigus-vulgaris-clinical-research-mSHWBjG4vM
Publisher
Springer International Publishing
Copyright
© Springer International Publishing AG 2018
ISBN
978-3-319-67758-3
Pages
53 –58
DOI
10.1007/978-3-319-67759-0_10
Publisher site
See Chapter on Publisher Site

Abstract

[Pemphigus vulgaris is a severe autoimmune disease diagnosed by painful erosions and extensive blistering of the skin and mucous membranes. Autoantibodies against epicutaneous antigens cause the blisters and erosions in pemphigus vulgaris. Among them, antigens such as desmoglein 1 and 3 are of particular importance. The aim of the author’s study was to determine the relationship between the levels of autoantibodies against desmoglein 1 and 3, using the enzyme-linked immunosorbent assay (ELISA) method in patients newly diagnosed with pemphigus vulgaris, and timeline of the disease among the patients hospitalized in Razi Hospital, Tehran, Iran, during 2013–2014.]

Published: Nov 27, 2017

Keywords: Pemphigus vulgaris; Pemphigus Disease Area Index (PDAI); Desmoglein; Anti-desmoglein; Autoantibodies; Remission; Enzyme-linked immunosorbent assay (ELISA)

There are no references for this article.